[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

European Hepatitis Diagnostics Market 2015: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

February 2015 | 295 pages | ID: E0F3B85782AEN
Venture Planning Group

US$ 5,520.00 US$ 6,900.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Complete report $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK).

Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.

The report provides the five-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals
  • Commercial/Private Labs
  • Blood Banks
  • Physician Offices
  • Public Health Labs For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Contains 295 pages and 67 tables
  • I. Introduction

    II. Hepatitis

    Worldwide Market and Technology Overview

    A. Background
    B. Hepatitis A
    C. Hepatitis B
    D. Hepatitis C
       CLASSIFICATION
       TRANSMISSION OF INFECTION
       OCCUPATIONAL HAZARDS
       ACUTE HEPATITIS
       DIAGNOSIS OF ACUTE INFECTION
       CHRONIC HEPATITIS
       HCV AND OTHER CHRONIC LIVER DISEASES
       ALCOHOLIC LIVER DISEASE
       HEPATITIS B COINFECTION
       CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
       DIAGNOSTIC TESTS
       POSSIBLE INDICATIONS FOR HCV RNA TESTING
       CONCLUSIONS AND FUTURE DIRECTION
    E. Hepatitis D
       HISTORICAL PERSPECTIVE
       EPIDEMIOLOGY
       HBV-HDV 'COINFECTION' VS. 'SUPERINFECTION'
       METHODS OF DETECTING HDV
       PREVENTION
    F. Hepatitis E
       BACKGROUND
       PREVALENCE OF THE DISEASE
       DIAGNOSTIC TESTS
       EPIDEMIOLOGIC SEROSURVEYS
       SEROLOGIC CROSS-REACTIVITY
    G. Hepatitis G
       VACCINES AND DRUGS
    H. Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
    I. Emerging Diagnostic Technologies
       1. MOLECULAR DIAGNOSTICS
       2. MONOCLONAL ANTIBODIES
       3. IMMUNOASSAYS
       4. DIFFERENTIAL LIGHT SCATTERING
       5. INFORMATION TECHNOLOGY
       6. ARTIFICIAL INTELLIGENCE
       7. LIPOSOMES
       8. FLOW CYTOMETRY
       9. CHROMATOGRAPHY
       10. DIAGNOSTIC IMAGING
       11. GEL MICRODROPLETS
       12. OTHER
    III. France: Market Size, Growth and Major Suppliers’ Sales and Market Shares
    IV. Germany: Market Size, Growth and Major Suppliers’ Sales and Market Shares
    V, Italy: Market Size, Growth and Major Suppliers’ Sales and Market Shares
    VI. Spain: Market Size, Growth and Major Suppliers’ Sales and Market Shares
    VII. UK: Market Size, Growth and Major Suppliers’ Sales and Market Shares

    X. ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets
       1. MARKETING APPROACHES
       2. PRODUCT COMPLEXITY
       3. CUSTOMER PREFERENCE
       4. ESTABLISHED SUPPLIERS
       5. EMERGING SUPPLIERS
       6. MAJOR TYPES OF DISTRIBUTORS
       7. MARKET SEGMENTATION

    XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    XII. COMPETITIVE ASSESSMENTS

    Abbott
    Affymetrix
    Beckman Coulter/Danaher
    Becton Dickinson
    bioMerieux
    Bio-Rad
    Cepheid
    Diamedix
    DiaSorin
    Eiken Chemical
    Enzo Biochem
    Fujirebio/Innogenetics
    Hologic/Gen-Probe
    ID Biomedical/GSK
    Kreatech
    Life Technology
    Lonza
    Nanogen/Elitech
    Novartis Diagnostics
    Ortho-Clinical Diagnostics
    Qiagen
    Roche
    Scienion
    Sequenom
    SeraCare
    Siemens
    Takara Bio
    Thermo Fisher
    Wallac/PE
    Wako

    LIST OF TABLES

    Major Companies Developing or Marketing Hepatitis Tests
    France HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
    France HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
    France HBs Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    France Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
    France Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
    France Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
    France Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
    France Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
    France HBc Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    France HBe Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    France ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
    France Hepatitis Testing Market Diagnostics Sales by Major Supplier
    France Hepatitis C Testing Market Diagnostics Sales by Major Supplier
    Germany HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany HBs Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany HBc Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany HBe Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany Hepatitis Testing Market Diagnostics Sales by Major Supplier
    Germany Hepatitis C Testing Market Diagnostics Sales by Major Supplier
    Italy HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy HBs Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy HBc Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy HBe Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy Hepatitis Testing Market Diagnostics Sales by Major Supplier
    Italy Hepatitis C Testing Market Diagnostics Sales by Major Supplier
    Spain Hbs Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain Hbc Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain Hbe Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain Hepatitis Testing Market Diagnostics Sales by Major Supplier
    Spain Hepatitis C Testing Market Diagnostics Sales by Major Supplier
    U.K. HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K. HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K. Hbs Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K. Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K. Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K. HBc Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K. HBe Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K. Hepatitis Testing Market Diagnostics Sales by Major Supplier
    U.K. Hepatitis C Testing Market Diagnostics Sales by Major Supplier


    More Publications